Brought to you by 
X4 Pharmaceuticals closes $37.5mm Series A round
15 Dec 2015
Executive Summary
X4 Pharmaceuticals Inc. (cancer start-up founded by ex-Genzyme exec Henri Termeer) raised $37.5mm through its Series A round. The company would not disclose investors, but the Form D filed with the SEC states that over 200 took part.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com